Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02846766
Title Study of Lenvatinib in Patients With Advanced Cancer and Aberrations in FGF/FGFR Signaling
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Teresa Helsten, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University of California, San Diego La Jolla California 92093 United States Details
Robert H. Lurie Comprehensive Cancer Center of Northwestern University Chicago Illinois 60611 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field